Medical Devices

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

WACKER is set to reveal a cost-saving XRF testing method and a breakthrough gamma-sterilizable medical adhesive, poised to impact two key sectors.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

A financially struggling healthcare firm makes a bold leap into neurotechnology, but can it compete with giants like Neuralink in the high-risk BCI race?

A new long-term deal for the INTERCEPT system highlights a critical shift towards proactive pathogen reduction to protect France's blood supply from global threats.

Swiss medtech vVARDIS secures a major Apollo investment, valuing it over $1B for its revolutionary non-invasive cavity treatment, Curodont™.

The medtech firm's Series B will advance its smart nerve stimulation system, which uses real-time biological feedback to offer personalized chronic pain therapy.

A major trial shows once-weekly rezafungin is as effective as daily drugs for preventing deadly fungal infections, heralding a new era for patient care.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

The company's SEAL™ device, targeting complex wide-neck aneurysms, completes its final submission, backed by a major US clinical trial.

A Cambridge firm's novel intracoronary liquid biopsy is creating a high-resolution data map of heart disease, promising a new era of precision medicine.

Medicana Health Group aims for 25,000 HPV shots annually, stepping into a major public health gap. But can this private initiative overcome cost barriers?

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

PSG midfielder Vitinha joins Vichy, signaling a major play in the booming male grooming market where athletic performance and skincare are the new power couple.

NerView Surgical's NerveSense™ wins FACIT's top award, spotlighting a growing ecosystem making Ontario a global leader in oncology innovation.

BrioHealth Solutions gets an FDA nod for a trial of its BrioVAD, a miniaturized heart pump designed for children with advanced heart failure.

Clinuvel's SCENESSE® advances to a pivotal Phase III trial with a novel EMA-backed design, focusing on patient experience and visible results.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

Danish medtech giant reels after US Medicare policy changes gut the sales outlook for its Kerecis wound care unit, forcing a major financial revision.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.